Novartis AG (NVS)
NYSE: NVS · Real-Time Price · USD
156.16
+2.35 (1.53%)
Oct 27, 2026, 9:58 AM EDT - Market open

Novartis AG Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
10,03113,98411,94114,8506,95524,021
Depreciation & Amortization
1,1754,7444,5998,1834,9944,949
Loss (Gain) From Sale of Assets
80116-74-180-308-646
Asset Writedown & Restructuring Costs
3765811,470941,711648
Loss (Gain) From Sale of Investments
-15-5045106260-14,638
Loss (Gain) on Equity Investments
312381311-214
Stock-Based Compensation
2991,0961,044865791700
Other Operating Activities
9,0691,721369-7,808195-607
Change in Accounts Receivable
-94-1,124-931-1,504-397-352
Change in Inventory
15134-225-546-560-102
Change in Accounts Payable
102-273-105479-181-111
Change in Other Net Operating Assets
-3,852-1,697-552-332-432-283
Operating Cash Flow
17,32519,14417,61914,45814,23615,071
Operating Cash Flow Growth
-17.79%8.65%21.86%1.56%-5.54%10.41%

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-1,668-1,548-1,366-1,060-916-1,066
Sale of Property, Plant & Equipment
321386237158211
Cash Acquisitions
-16,692-2,916-4,018-3,561-832-259
Divestitures
93-881073-854
Sale (Purchase) of Intangibles
-1,544-2,188-2,368262-1,153-804
Investment in Securities
8931,8745310,8494,6566,816
Other Investing Activities
195-24-7-1,134-437-744
Investing Cash Flow
-18,691-4,877-7,5135,5961,4684,208

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Short-Term Debt Issued
-5958546252-
Long-Term Debt Issued
-6,0986,143---
Total Debt Issued
17,7356,1037,101546252-
Short-Term Debt Repaid
---289---3,547
Long-Term Debt Repaid
--3,673-2,422-2,481-2,837-2,440
Lease Payments
-280-281-262-258-262-278
Total Debt Repaid
-1,544-3,673-2,711-2,481-2,837-5,987
Net Debt Issued (Repaid)
16,1912,4304,390-1,935-2,585-5,987
Issuance of Common Stock
18273015310053
Repurchase of Common Stock
-6,252-9,212-8,331-8,719-10,652-3,057
Common Dividends Paid
-9,068-7,818-7,624-7,255-7,506-7,368
Other Financing Activities
-111-294-2073,4788195
Financing Cash Flow
778-14,867-11,742-14,278-20,562-16,264

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Foreign Exchange Rate Adjustments
-98576-298100-32-266
Net Cash Flow
-686-24-1,9345,876-4,8902,749

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
15,65717,59616,25313,39813,32014,005
Free Cash Flow Growth
-20.02%8.26%21.31%0.59%-4.89%13.17%
Free Cash Flow Margin
27.29%31.05%31.42%28.71%30.65%31.85%
Free Cash Flow Per Share
8.169.007.996.406.066.20
Levered Free Cash Flow
4,36312,11512,03813,6767,31111,774
Unlevered Free Cash Flow
5,34812,83012,66714,2107,81112,266
Free Cash Flow After Leases
15,37717,31515,99113,14013,05813,727

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Interest Paid
211981855751667643
Cash Income Tax Paid
9812,5622,2582,7871,7021,856
Change in Working Capital
-3,693-3,060-1,813-1,903-1,570-848
SEC Filings: 10-K · 10-Q